11 points | by Anon84 11 hours ago ago
1 comments
COVID vaccines target a relatively static spike protein. Since pancreatic tumors are genetically diverse, is the "personalized" approach for every patient scalable, or will it remain a boutique treatment for the wealthy?
COVID vaccines target a relatively static spike protein. Since pancreatic tumors are genetically diverse, is the "personalized" approach for every patient scalable, or will it remain a boutique treatment for the wealthy?